Background: Dimethoate (DM), one of the most widely used systemic organophosphate insecticide, has been reported to exert toxic effects after long-time subchronic exposure. This study aims at investigating the toxic effect of DM on liver after repeated administration of low doses of DM in rats. Methods: Twenty Sprague-Dawley rats were randomly divided into the control group (n = 10) and the DM group (n = 10). After 2 weeks' exposure to DM at low dosage (5 mg/kg), biochemical parameters of hepatic functions were measured, histology and CYP450 expressed in liver was detected. The activities of CYP1A2, CYP2C11, CYP2D1, and CYP3A2 were evaluated by the Cocktail method. Results: The level of AChE (acetylcholinesterase) was significantly decreased, hepatic functions were damaged and the mRNA level of CYP2D1 was significantly increased in the DM group (p < 0.05). The pharmacokinetics of probe drug revealed AUC(0-t), AUC(0-∞), t1/2 and Cmax of metoprolol was shorten in the DM group (p < 0.05). However, there were no statistical differences in MRT, t1/2, CL and Tmax for phenacetin, tolbutamide and midazolam. Conclusions: A low dosage of DM could induce the activity of CYP2D1 in liver and increase the metabolism of metoprolol when exposed for 2 weeks.

Keywords:
Dimethoate, CYP450, Liver, Pharmacokinetics
1.
Zhang Y, Hou Y, Zhang Y, Chen J, Chen F, Liao X, Hu X: Reduction of diazinon and dimethoate in apple juice by pulsed electric field treatment. J Sci Food Agric 2012;92:743-750.
2.
Guo R, Ren X, Ren H: A new method for analysis of the toxicity of organophosphorus pesticide, dimethoate on rotifer based on response surface methodology. J Hazard Mater 2012;237-238:270-276.
3.
Montesano MA, Olsson AO, Kuklenyik P, Needham LL, Bradman AS, Barr DB: Method for determination of acephate, methamidophos, omethoate, dimethoate, ethylenethiourea and propylenethiourea in human urine using high-performance liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. J Expo Sci Environ Epidemiol 2007;17:321-330.
4.
Saafi-Ben Salah EB, El Arem A, Louedi M, Saoudi M, Elfeki A, Zakhama A, Najjar MF, Hammami M, Achour L: Antioxidant-rich date palm fruit extract inhibits oxidative stress and nephrotoxicity induced by dimethoate in rat. J Physiol Biochem 2012;68:47-58.
5.
Salm P, Taylor PJ, Roberts D, de Silva J: Liquid chromatography-tandem mass spectrometry method for the simultaneous quantitative determination of the organophosphorus pesticides dimethoate, fenthion, diazinon and chlorpyrifos in human blood. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:568-574.
6.
Ayed-Boussema I, Rjiba K, Mnasri N, Moussa A, Bacha H: Genotoxicity evaluation of dimethoate to experimental mice by micronucleus, chromosome aberration tests, and comet assay. Int J Toxicol 2012;31:78-85.
7.
Ben Amara I, Soudani N, Hakim A, Bouaziz H, Troudi A, Zeghal KM, Zeghal N: Dimethoate-induced oxidative damage in erythrocytes of female adult rats: possible protective effect of vitamin E and selenium supplemented to diet. Toxicol Ind Health 2012;28:222-237.
8.
Ayed-Boussema I, Rjiba K, Moussa A, Mnasri N, Bacha H: Genotoxicity associated with oxidative damage in the liver and kidney of mice exposed to dimethoate subchronic intoxication. Environ Sci Pollut Res Int 2012;19:458-466.
9.
Farag AT, El-Aswad AF, Shaaban NA: Assessment of reproductive toxicity of orally administered technical dimethoate in male mice. Reprod Toxicol 2007;23:232-238.
10.
Hagar HH, Azza H, Fahmy: A biochemical, histochemical, and ultrastructural evaluation of the effect of dimethoate intoxication on rat pancreas. Toxicol Lett 2002;133:161-170.
11.
Kamath V, Rajini PS: Altered glucose homeostasis and oxidative impairment in pancreas of rats subjected to dimethoate intoxication. Toxicology 2007;231:137-146.
12.
Sharma Y, Bashir S, Irshad M, Nag TC, Dogra TD: Dimethoate-induced effects on antioxidant status of liver and brain of rats following subchronic exposure. Toxicology 2005;215:173-181.
13.
Rodríguez Arcas MJ, García-Jiménez E, Martínez-Martínez F, Conesa-Zamora P: Role of CYP450 in pharmacokinetics and pharmacogenetics of antihypertensive drugs. Farm Hosp 2011;35:84-92.
14.
Xu X, Zhang XA, Wang DW: The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev 2011;63:597-609.
15.
Sayim F: Dimethoate-induced biochemical and histopathological changes in the liver of rats. Exp Toxicol Pathol 2007;59:237-243.
16.
Hu L, Xu R, Wang Z, Chen X, Ma J, Pan J, Wang X: Simultaneous determination of four cytochrome P450 probe drugs in rat plasma by a simple liquid chromatography - mass spectrometry method. Lat Am J Pharm 2012;31:889-895.
17.
Wang X, Chen M, Chen X, Ma J, Wen C, Pan J, Hu L, Lin G: The effects of acute hydrogen sulfide poisoning on cytochrome P450 isoforms activity in rats. Biomed Res Int 2014;2014:209393.
18.
Goh BC, Reddy NJ, Dandamudi UB, Laubscher KH, Peckham T, Hodge JP, Suttle AB, Arumugham T, Xu Y, Xu CF, Lager J, Dar MM, Lewis LD: An evaluation of the drug interaction potential of pazopanib, an oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, using a modified cooperstown 5+1 cocktail in patients with advanced solid tumors. Clin Pharmacol Ther 2010;88:652-659.
19.
Kanebratt KP, Diczfalusy U, Backstrom T, Sparve E, Bredberg E, Bottiger Y, Andersson TB, Bertilsson L: Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol. Clin Pharmacol Ther 2008;84:589-594.
20.
Venhorst J, ter Laak AM, Commandeur JN, Funae Y, Hiroi T, Vermeulen NP: Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J Med Chem 2003;46:74-86.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.